Benzinga | May 4, 2021 04:35PM EDT

TransMedics Group Q1 EPS $(0.29), Sales $7.10M, Both Inline

TransMedics Group (NASDAQ:TMDX) reported quarterly losses of $(0.29) per share which met the analyst consensus estimate. This is a 30.95 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $7.10 million which met the analyst consensus estimate. This is a 5.71 percent decrease over sales of $7.53 million the same period last year.